GILD FY 2018 Earnings Report — Gilead Sciences, Inc. Revenue & Financial Results | Market Cap Arena

Gilead Sciences, Inc.GILD

FY 2018 Earnings

Reported February 25, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$22.1B	—	$26.1B	—	-15.2%
Op. Income	$8.2B	—	$14.1B	—	-41.9%
Gross Margin	78.1%	—	83.3%	—	-5.2pp
Net Margin	24.7%	—	17.7%	—	6.9pp
EPS (Diluted)	$4.17	—	$3.51	—	18.8%
Free Cash Flow	$7.5B	—	$11.3B	—	-33.9%

Revenue Flow

Item	Amount
REVENUE	$22.1B
Cost of Revenue	$4.9B
GROSS PROFIT	$17.3B
R&D Expenses	$3.9B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$4.1B
Other Expenses	$0
Operating Expenses	$8.0B
Cost & Expenses	$12.8B
OPERATING INCOME	$8.2B
Interest Income	$0
Interest Expense	$1.1B
Other Income/Expenses	-$401M
INCOME BEFORE TAX	$7.8B
Income Tax Expense	$2.3B
Net Income from Continuing Ops	$5.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.5B
D&A	$1.4B
EBIT	$8.9B
EBITDA	$10.3B
EPS	$4
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$22.1B
Cost of Revenue	$4.9B
GROSS PROFIT	$17.3B
R&D Expenses	$3.9B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$4.1B
Other Expenses	$0
Operating Expenses	$8.0B
Cost & Expenses	$12.8B
OPERATING INCOME	$8.2B
Interest Income	$0
Interest Expense	$1.1B
Other Income/Expenses	-$401M
INCOME BEFORE TAX	$7.8B
Income Tax Expense	$2.3B
Net Income from Continuing Ops	$5.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.5B
D&A	$1.4B
EBIT	$8.9B
EBITDA	$10.3B
EPS	$4
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$5.5B
Depreciation & Amortization	$1.4B
Stock-Based Compensation	$845M
Deferred Income Tax	$289M
Other Non-Cash Items	$1.3B
Change in Working Capital	-$939M
OPERATING CASH FLOW	$8.4B
Capital Expenditure	-$924M
Acquisitions (Net)	$0
Purchases of Investments	-$10.4B
Sales/Maturities of Investments	$25.9B
Other Investing Activities	-$190M
NET CASH FROM INVESTING	$14.4B
Net Debt Issuance	-$6.3B
Common Stock Repurchased	-$2.9B
Common Dividends Paid	-$3.0B
Other Financing Activities	-$486M
NET CASH FROM FINANCING	-$12.3B
FREE CASH FLOW	$7.5B
Net Change in Cash	$10.4B

Balance Sheet

Item	Amount
Cash & Equivalents	$17.9B
Short-Term Investments	$12.1B
Net Receivables	$3.3B
Inventory	$814M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$35.8B
PP&E (Net)	$4.0B
Goodwill	$4.1B
Intangible Assets	$15.7B
Long-Term Investments	$1.4B
Tax Assets	$0
Other Non-Current Assets	$2.6B
TOTAL NON-CURRENT ASSETS	$27.8B
TOTAL ASSETS	$63.7B
Account Payables	$790M
Short-Term Debt	$2.7B
Deferred Revenue	$0
Other Current Liabilities	$555M
TOTAL CURRENT LIABILITIES	$10.6B
Long-Term Debt	$24.6B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$7.0B
TOTAL NON-CURRENT LIABILITIES	$31.5B
TOTAL LIABILITIES	$42.1B
Common Stock	$1M
Additional Paid-In Capital	$2.3B
Retained Earnings	$19.0B
Treasury Stock	$0
Accum. Other Comp. Income	$80M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$21.4B
Minority Interest	$147M
TOTAL EQUITY	$21.5B
TOTAL LIABILITIES & EQUITY	$63.7B
Total Debt	$27.3B
Net Debt	$9.4B